Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes and sells safety syringes in the United States. The company is headquartered in Melville, New York.
| Revenue (TTM) | 396,900 |
| Gross Profit (TTM) | -423,123 |
| EBITDA | $-16.39M |
| Operating Margin | -2369.00% |
| Return on Equity | -380.30% |
| Return on Assets | -10.30% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $9.12 |
| Price-to-Book | 0.43 |
| Price-to-Sales (TTM) | 193.00 |
| EV/Revenue | 176.22 |
| EV/EBITDA | -2.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $42.32M |
| Float | $36.79M |
| % Insiders | 4.55% |
| % Institutions | 24.34% |
Volatility is currently expanding